etodolac NDC 83980-029

NDC codes

FDA NDC Directory

Product NDC (as listed)83980-029Labeler and product segments. Claims need a package NDC.

Product NDC at billing width83980-0029Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
83980-029-01	83980002901	100 TABLET in 1 BOTTLE (83980-029-01)Marketed from Feb 13, 2026
83980-029-10	83980002910	1000 TABLET in 1 BOTTLE (83980-029-10)Marketed from Feb 13, 2026
83980-029-13	83980002913	30 TABLET in 1 BOTTLE (83980-029-13)Marketed from Feb 13, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): etodolac
Generic name (nonproprietary): etodolac
Active ingredients: Etodolac — 400 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Ipca Laboratories Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204729
Marketing start: Feb 13, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 83980-029_4064e892-4c7a-46a7-9114-3e2bf466e597SPL ID 4064e892-4c7a-46a7-9114-3e2bf466e597SPL set ID f50a93ca-584a-4205-a79b-31bafdd309c2RxCUI 197686, 199390UNII 2M36281008
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N483980002901 followed by a unit qualifier and the quantity

Package 83980-0029-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 29, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of etodolac tablets, and other treatment options before deciding to use etodolac tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Etodolac tablets are indicated: • For acute and long-term use in the management of signs and symptoms of the following: 1. Osteoarthritis 2. Rheumatoid arthritis • For the management of acute pain

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 204729

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204729
Product	Strength	Form · route	Labeler	Product NDC
etodolac	Etodolac 500 mg/1	TabletOral	Ipca Laboratories Limited	83980-030